Ying Lü
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 14
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 24
- Cancer Research top 1%
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 8
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 14
- Biological Psychiatry top 5%
-
- Nanoplatforms for cancer theranostics 14
-
- Cancer Cells and Metastasis 11
-
- Autophagy in Disease and Therapy 8
- Journals
- International Journal of Pharmaceutics (8 papers)Journal of the American College of Cardiology (7 papers)Journal of Controlled Release (7 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Ying Lü
245 papers receiving 7.6k citations
Peers
Comparison fields: 5 of 165
- Pharmaceutical Science 637
- Biomaterials 1.2k
- Cancer Research 1.1k
- Molecular Biology 3.7k
- Biological Psychiatry 101
Countries citing papers authored by Ying Lü
This map shows the geographic impact of Ying Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Lü more than expected).
Fields of papers citing papers by Ying Lü
This network shows the impact of papers produced by Ying Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Lü. The network helps show where Ying Lü may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 50 | |
| 4 | 2024 | 63 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 30 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 76 | |
| 12 | 2019 | 27 | |
| 13 | 2018 | 145 | |
| 14 | 2018 | 68 | |
| 15 | Zinc supplementation ameliorates ER stress and autophagy in liver in a rat model of type 2 diabetes mellitus | 2016 | 6 |
| 16 | 2016 | 1 | |
| 17 | [Inhibitory effect of salinomycin on human breast cancer cells MDA-MB-231 proliferation through Hedgehog signaling pathway]. | 2015 | 6 |
| 18 | Development and Evaluation of Transferrin-Stabilized Paclitaxel Nanocrystal Formulation | 2014 | 2 |
| 19 | 2008 | 19 | |
| 20 | 2005 | 230 |
About Ying Lü
Ying Lü is a scholar working on Pharmaceutical Science, Biomaterials, Cancer Research, Nephrology and Immunology, having authored 254 papers that have together received 7.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (24 papers), MicroRNA in disease regulation (17 papers), Advanced Drug Delivery Systems (14 papers), Nanoplatforms for cancer theranostics (14 papers), RNA Interference and Gene Delivery (14 papers), Cancer Cells and Metastasis (11 papers), Autophagy in Disease and Therapy (8 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Pharmaceutical Science (637 citations), Biomaterials (1.2k citations), Cancer Research (1.1k citations), Molecular Biology (3.7k citations) and Biological Psychiatry (101 citations). Ying Lü has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Kinam Park, Anders Bennick, Jun Mao, Yanqiang Zhong, Jie Gao, Hao Zou, C.H. Arrowsmith, Bo Song, Tao Qin and Zhiguo Sun. Their work appears in journals such as International Journal of Pharmaceutics, Journal of the American College of Cardiology, Journal of Controlled Release, Nanomedicine and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.